These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
250 related items for PubMed ID: 8047870
1. Erythromycin induced Torsades de Pointes: case report and review of the literature. Rezkalla MA, Pochop C. S D J Med; 1994 May; 47(5):161-4. PubMed ID: 8047870 [Abstract] [Full Text] [Related]
2. A review of erythromycin-induced malignant tachyarrhythmia--torsade de pointes. A case report. Katapadi K, Kostandy G, Katapadi M, Hussain KM, Schifter D. Angiology; 1997 Sep; 48(9):821-6. PubMed ID: 9313632 [Abstract] [Full Text] [Related]
3. QT prolongation and development of torsades de pointes with the concomitant administration of oral erythromycin base and quinidine. Lin JC, Quasny HA. Pharmacotherapy; 1997 Sep; 17(3):626-30. PubMed ID: 9165570 [Abstract] [Full Text] [Related]
4. QT interval prolongation and torsades de pointes due to erythromycin lactobionate. Oberg KC, Bauman JL. Pharmacotherapy; 1995 Sep; 15(6):687-92. PubMed ID: 8602374 [Abstract] [Full Text] [Related]
5. [Access of torsades de pointes in Legionnaires' disease: an uncommon adverse effect of erythromycin]. Staikowsky F, Haziza F, Guidet B, Vassal T, Offenstadt G. Rev Pneumol Clin; 1991 Sep; 47(2):92-4. PubMed ID: 1759106 [Abstract] [Full Text] [Related]
6. Erythromycin-induced QT prolongation and polymorphic ventricular tachycardia (torsades de pointes): case report and review. Brandriss MW, Richardson WS, Barold SS. Clin Infect Dis; 1994 Jun; 18(6):995-8. PubMed ID: 8086567 [Abstract] [Full Text] [Related]
7. Erythromycin-induced torsades de pointes and ventricular fibrillation in a patient with Legionella pneumonia. de Koning J, van der Hoeven H, Hamer B, Thompson J. Neth J Med; 1994 Apr; 44(4):131-5. PubMed ID: 8196823 [Abstract] [Full Text] [Related]
11. [Torsades de pointes ventricular tachycardia induced by intravenous amiodarone]. Makai A, Rudas L, Liszkai G, Fazekas T. Orv Hetil; 2003 Feb 02; 144(5):241-7. PubMed ID: 12647553 [Abstract] [Full Text] [Related]
12. Moxifloxacin and torsade de pointes. Dale KM, Lertsburapa K, Kluger J, White CM. Ann Pharmacother; 2007 Feb 02; 41(2):336-40. PubMed ID: 17284508 [Abstract] [Full Text] [Related]
13. Drug-induced torsades de pointes in one patient with congenital long QT syndrome. Hsieh MH, Chen SA, Chiang CE, Tai CT, Lee SH, Wen ZC, Chang MS. Int J Cardiol; 1996 Apr 19; 54(1):85-8. PubMed ID: 8792191 [Abstract] [Full Text] [Related]
16. Torsades de Pointes after Ondansetron Infusion in 2 Patients. Lee DY, Trinh T, Roy SK. Tex Heart Inst J; 2017 Oct 19; 44(5):366-369. PubMed ID: 29259513 [Abstract] [Full Text] [Related]
17. Torsades de pointes associated with acquired long QT syndrome: observation of 7 cases. Takahashi N, Ito M, Inoue T, Koumatsu K, Takeshita Y, Tsumabuki S, Tamura M, Inoue K, Maeda T, Saikawa T. J Cardiol; 1993 Oct 19; 23(1):99-106. PubMed ID: 8164140 [Abstract] [Full Text] [Related]
18. Torsades de pointes complicating pentamidine therapy of Pneumocystis carinii pneumonia in acute myelogenous leukemia. Otsuka M, Kanamori H, Sasaki S, Taguchi J, Harano H, Ogawa K, Matsuzaki M, Mohri H, Okubo T, Sumita S, Ochiai H. Intern Med; 1997 Oct 19; 36(10):705-8. PubMed ID: 9372331 [Abstract] [Full Text] [Related]
19. [Takotsubo cardiomyopathy associated with torsades de pointes and long QT interval: a case report]. Okada T, Miyata S, Hashimoto K, Maie K, Mochizuki S. J Cardiol; 2007 Jul 19; 50(1):83-8. PubMed ID: 17685032 [Abstract] [Full Text] [Related]
20. QT interval prolongation, torsade de pointes and renal disease. Patanè S, Marte F, Di Bella G, Currò A, Coglitore S. Int J Cardiol; 2008 Nov 12; 130(2):e71-3. PubMed ID: 18255176 [Abstract] [Full Text] [Related] Page: [Next] [New Search]